Trials / Completed
CompletedNCT01845688
Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy
Efficacy and Safety Evaluation of QingReMoShen Granule in the Treatment of Idiopathic Membranous Nephropathy : A Randomized Double-Blind Controlled Clinical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- wanglin · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the clinical safety and efficacy of QingReMoShen Granule to treat idiopathic membranous nephropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Losartan Tablets & QingReMoShen Granule | |
| DRUG | Losartan Tablets & Placebo Granule |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2016-02-01
- Completion
- 2016-09-01
- First posted
- 2013-05-03
- Last updated
- 2023-04-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01845688. Inclusion in this directory is not an endorsement.